Status:
RECRUITING
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Heparin-induced Thrombocytopenia
HIT
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators would like to analyze platelet/leukoplak activation, quantify and morphologically characterize these aggregates using in vitro analysis, directly on whole blood from adult patients w...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Any adult patient suspected of having HIT, with a positive anti-PF4/H antibody test
- Patient signed consent to study participation
- Patient with social security coverage
Exclusion
- All adult patients with suspected HIT and negative anti-PF4/H antibody test.
- Protected adults (guardianship, under curators) or deprived of liberty
Key Trial Info
Start Date :
April 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06033300
Start Date
April 17 2023
End Date
April 1 2026
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480